Information on the Target
Millie is an innovative maternity clinic dedicated to transforming maternal care through a combination of midwifery-led practices and advanced technology. The clinic provides comprehensive support throughout pregnancy, aligning with health systems to address the full spectrum of care needs. Utilizing an AI-integrated platform and remote monitoring tools, Millie aims to deliver proactive and continuous care, resulting in improved health outcomes and reduced costs for payors. To date, Millie has served over 1,500 patients and successfully facilitated the delivery of numerous babies, while also offering preconception and ongoing gynecological services.
Industry Overview in the Target’s Specific Country
The United States currently exhibits the highest expenses associated with maternity care globally, yet still suffers from poor outcomes for both birthing parents and infants. As of 2022, the maternal mortality rate reached 22 deaths per 100,000 live births, with 80% of these fatalities deemed preventable. Furthermore, the nation experiences elevated rates of C-sections, preterm births, NICU stays, and perinatal depression, particularly among historically marginalized communities and those residing in maternity care deserts that lack sufficient resources.
The underlying issues within maternal care in the U.S. are attributed to a fragmented and reactive healthcare model characterized by limited postpartum support, over-medicalization of births, inadequate education for expectant parents, and shortages of obstetricians and gynecologists (OBGYNs). By incorporating midwives into the maternal care process, many of these gaps may be effectively addressed. Midwives are trained to support both the physical and emotional needs of birthing individuals throughout their pregnancy journey, providing essential clinical care while promoting education on topics that include nutrition and newborn care.
There is a growing necessity for more holistic maternal care strategies within the U.S. healthcare framework. Millie’s approach of integrating midwifery practices with modern technology directly responds to the challenges posed by the current suboptimal system, aiming to enhance maternal health outcomes across diverse populations.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The Series A investment in Millie is a strategic move aimed at facilitating the growth and expansion of a company dedicated to overcoming the prevailing maternal health crisis in the U.S. By addressing shortcomings in care delivery and promoting health equity, Millie's innovative approach offers significant potential to improve maternal health outcomes while reducing healthcare costs. The infusion of capital will aid in the expansion of Millie's operations, allowing the clinic to deepen its partnerships with various health systems and extend its reach to underserved communities.
Information About the Investor
Coyote Ventures is an investment firm committed to supporting companies that harness technology to address critical societal challenges. In its latest funding round, Coyote Ventures is joining forces with other prominent investors including TMV, Foreground Capital, Pivotal Ventures, Ingeborg Investments, BBG Ventures, and Amboy Street Ventures to bolster Millie's mission. This collaborative investment signifies a strong belief in Millie's potential to reshape the maternal healthcare landscape with its innovative model and commitment to health equity.
View of Dealert
Millie's approach to maternal healthcare represents a significant advancement in addressing the pressing issues surrounding maternal mortality and inadequate care. By leveraging midwifery practices and integrating innovative technology, Millie has positioned itself as a frontrunner in the push for health equity in maternal care. From a deal analysis perspective, the investment holds promising potential for substantial returns, not only financially but also in terms of social impact.
The company’s focus on high-demand populations and culturally competent care further enhances its relevance in today's healthcare landscape, where accessibility and inclusivity are paramount. As the maternal health crisis persists, investment in solutions like Millie could create transformative change, thereby reducing both costs and improving health outcomes across the board.
Furthermore, the proven actuarial savings model that Millie offers to payors speaks to its sustainability and viability in the long-term market. The combination of robust leadership, innovative practices, and a clear vision for future expansion solidifies Millie’s standing as a worthwhile investment. Overall, this deal encapsulates a strategic approach to enhancing patient care while fostering health equity in maternal health.
Similar Deals
SV Health Investors' Dementia Discovery Fund (DDF) → Leal Therapeutics, Inc.
2025
53 Stations → GoodShip, Function Health, Stealth Restaurant Tech Company, Wealth.com, GreenLite
2024
Andreessen Horowitz, Paradigm, Union Square Ventures, First Round Capital, Coinbase Ventures → Farcaster
2024
Jeff Bezos, Lux Capital, Thrive Capital, OpenAI, Redpoint Ventures, Bond → Physical Intelligence
2024
Coyote Ventures
invested in
Millie
in 2025
in a Series A deal